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Abstract
Background: Cocaine addiction continues to be a major heath concern, and despite public health intervention there is a lack 
of efficient pharmacological treatment options. A newly identified potential target are the group I metabotropic glutamate 
receptors, with allosteric modulators showing particular promise.
Methods: We evaluated the capacity of group I metabotropic glutamate receptors to induce functional responses in ex vivo 
striatal slices from rats with (1) acute cocaine self-administration, (2) chronic cocaine self-administration, and (3) 60 days 
cocaine self-administration withdrawal by Western blot and extracellular recordings of synaptic transmission.
Results: We found that striatal group I metabotropic glutamate receptors are the principal mediator of the mGluR1/5 agonist 
(RS)-3,5-dihydroxyphenylglycine-induced cAMP responsive-element binding protein phosphorylation. Both acute and chronic 
cocaine self-administration blunted group I metabotropic glutamate receptor effects on cAMP responsive-element binding 
protein phosphorylation in the striatum, which correlated with the capacity to induce long-term depression, an effect that 
was maintained 60 days after chronic cocaine self-administration withdrawal. In the nucleus accumbens, the principal brain 
region mediating the rewarding effects of drugs, chronic cocaine self-administration blunted group I metabotropic glutamate 
receptor stimulation of extracellular signal-regulated protein kinases 1/2 and cAMP responsive-element binding protein. 
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Interestingly, the group I metabotropic glutamate receptor antagonist/inverse-agonist, 2-methyl-6-(phenylethynyl)pyridine 
hydrochloride, led to a specific increase in cAMP responsive-element binding protein phosphorylation after chronic cocaine 
self-administration, specifically in the nucleus accumbens, but not in the striatum.
Conclusions: Prolonged cocaine self-administration, through withdrawal, leads to a blunting of group I  metabotropic 
glutamate receptor responses in the striatum. In addition, specifically in the accumbens, group I metabotropic glutamate 
receptor signaling to cAMP responsive-element binding protein shifts from an agonist-induced to an antagonist-induced 
cAMP responsive-element binding protein phosphorylation.
Keywords: extracellular signal-regulated protein kinase1 and 2, cAMP response element binding protein, cocaine self-
administration withdrawal, striatum, long term depression.
Introduction
Cocaine addiction is a complex multifaceted condition, which 
thus far has impeded the development of efficient pharmacologi-
cal treatment options (Shorter et al., 2015; Wolf, 2016). Repeated 
cocaine consumption decreases expression of metabotropic glu-
tamate 5 receptors (mGluR5) in the striatum, a subcortical region 
critical in mediating the effects of drugs of abuse (Ghasemzadeh 
et al., 2009; Knackstedt et al., 2010; Martinez et al., 2014; Milella 
et al., 2014; Pomierny-Chamiolo et al., 2015; Terbeck et al., 2015). 
The critical role of the glutamatergic system in humans is sup-
ported by preclinical studies that suggest that striatal glutamate 
homeostasis is disrupted following cocaine exposure (Martinez 
et al., 2014), an observation made earlier in rodents (Knackstedt 
and Kalivas, 2009; Moussawi et al., 2009). Indeed, glutamate trans-
mission, and particularly mGluR1/5, are central in mood disorders 
as well as the regulation of the behavioral and molecular responses 
to cocaine (Chiamulera et al., 2001; Swanson et al., 2001; Kalivas 
et al., 2005; Kenny et al., 2005; Volkow et al., 2005; Kumaresan et al., 
2009; Moussawi et al., 2009; Akkus et al., 2014; Terbeck et al., 2015; 
Perry et al., 2016). In recent years, mGluR5 have come in focus as 
promising targets for the treatment of various aspects of cocaine 
abuse; positive allosteric modulators of mGluR5 facilitate extinc-
tion of cocaine-associated contextual memory (Cleva et al., 2011; 
Perry et al., 2016), whereas negative allosteric modulators, phar-
macological blockade, or genetic deletion decrease CSA, cocaine 
seeking, and conditioned place preference (Chiamulera et  al., 
2001; Kenny et al., 2005; Kumaresan et al., 2009; Moussawi et al., 
2009; Wang et al., 2013; Knackstedt et al., 2014; Gould et al., 2015; 
Schmidt et al., 2015; Mihov and Hasler, 2016).
Repeated drug administration affects synaptic transmis-
sion and induces the formation of long-lasting drug-associated 
memories, changes maintained after prolonged cocaine with-
drawal (Hyman et al., 2006; Collingridge et al., 2010; Knackstedt 
et  al., 2010; Pomierny-Chamiolo et  al., 2015; Wolf, 2016). The 
neuronal adaptations induced by cocaine intake can be evi-
denced by altered receptor responses, signal transduction, and 
gene expression, which finally affect synaptic transmission and 
plasticity (McClung and Nestler, 2008; Kalivas, 2009; Knackstedt 
et al., 2010). Certainly, chronic exposure to cocaine profoundly 
alters both long-term potentiation and long-term depression 
(LTD) at excitatory cortico-striatal and cortico-accumbal syn-
apses. More particularly, LTD inhibition appears to be prominent 
in the induction of addictive behaviors. As a matter of fact, the 
loss of the ability to trigger N-methyl-D-aspartate-dependent 
LTD at excitatory cortico-accumbal synapses is crucial for the 
transition to addiction and vulnerability to relapse after pro-
longed cocaine intake (Kasanetz et al., 2010). Nevertheless, this 
is not restricted to N-methyl-D-aspartate-dependent electrically 
induced LTD, as chemically induced LTD by mGluR1/5 stimulation 
(mGluR1/5-LTD) is also dramatically inhibited at excitatory syn-
apses by cocaine exposure in the dorsal striatum and remains 
inhibited even 3 weeks after withdrawal (Knackstedt et al., 2014).
In most neuronal cell types, mGluR1/5-LTD depends on the 
activation of extracellular signal-regulated protein kinases 1/2 
(ERK1/2) (Gallagher et  al., 2004; Grueter et  al., 2006). ERK1/2 is 
important for the regulation of gene expression through the 
transcription factors cAMP responsive-element binding pro-
tein (CREB) and E-26 like protein. ERK1/2 and CREB activation 
are associated with in vivo effects of cocaine. ERK1/2 is linked 
to cocaine reward (Valjent et al., 2000) as well as the develop-
ment of locomotor sensitization (Valjent et al., 2006), whereas 
CREB is critical for the rewarding effects of cocaine (Self et al., 
1998; McClung and Nestler, 2003; Larson et al., 2011). In light of 
the potential changes cocaine can cause to cell signaling and 
neuronal function, we sought to understand the impact of sev-
eral stages of CSA on mGluR1/5 function in the dorsal and ventral 
striatum, with a particular focus on the above pathways.
Methods
All experiments were carried out in accordance with the 
European Community Council Directive of September 22, 2010 
(2010/63/UE) as well as the European Communities Council 
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of efficient treatment options. One of the major challenges in cocaine addiction are the long-lasting changes and memories that 
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Directive 86/609/EEC. The cocaine self-administration (CSA) and 
following signal-transduction pathway studies were carried out 
in Barcelona and approved by the Ethics Committee for Human 
and Animal Research of the Autonomous University of Barcelona. 
Electrophysiological recordings as well as signal-transduction 
studies were carried out in Montpellier and approved by the 
local section of the Comité National de Réﬂexion Ethique sur 
l’Expérimentation Animale’ (C2EA-36), Montpellier.
Subjects
Male Sprague-Dawley rats (including OFA-Sprague Dawley) weigh-
ing 210 to 250 g were obtained from the Animal Service, Universitat 
Autònoma de Barcelona, Spain and the Centre d’Elevage Depré, 
France. Rats were housed individually in a climate-controlled 
environment at 19°C to 23°C on a 12-h-light/-dark cycle (lights on 
8 am). Behavioral studies were carried out during the light cycle 
except initial overnight sucrose training. Rats were allowed ad libi-
tum access to food and water except during sucrose training that 
was facilitated by partial food restriction for 1 week to maintain 
rat bodyweight at 85% of the theoretical weight.
Surgery and Behavioral Conditioning
A detailed description of the surgery and conditioning para-
digms has been described previously (Hoffmann et  al., 2012). 
Rats were maintained at 85% bodyweight during sucrose train-
ing (Figure  1). Rats were equally distributed into 2 groups of 
operant chambers (LE 1005, Panlab S.L.U.) with either the right or 
left lever active to obtain sucrose pellets. One active lever press 
gave one pellet (45 mg Bio-Serv, Frenchtown, NJ) and was associ-
ated with 5 seconds of light on over the active lever. Following 
the initial 5 seconds of light on was a 10-second period with the 
active lever inactive and house lights off. Inactive lever press 
had no programmed consequence. Overnight sessions permit-
ted consumption of a maximum 100 pellets in 14 hours. Lever 
pressing was considered acquired when rats obtained 100 
sucrose pellets during 2 additional 2-hour sessions in the light 
cycle. After sucrose training, the rats were allowed to recover 
weight before surgery. To implant a jugular catheter, rats were 
anesthetized with isoﬂurane and the catheter was implanted 
in the jugular vein, passed under the skin to the back where it 
exited. To relieve postoperational pain s.c. meloxicam (1.5 mg/kg 
Metacam 0.3 mL/kg, Boehringer) was injected daily for 3 days. 
Rats were allowed a minimum 1 week of recovery before they 
started saline self-administration (SSA) or CSA. Intravenous 
infusions of saline or cocaine were administered by a syringe 
pump (Samford, CT). Behavioral equipment and data collection 
were controlled by the Packwin Software (Panlab S.L.U). Rats 
self-administered saline or cocaine during a single 2-h session 
(acute SSA, acute CSA) or for daily sessions (chronic CSA) on a 
fixed ratio 1 schedule (FR1) (supplementary Figure 1A). The cues 
were as for sucrose training. However, one active lever press 
delivered i.v. saline or cocaine (0.5 mg/kg/0.1 mL for 5 seconds) 
during the 2-h session with a maximum of 50 injections per ses-
sion. Then 16 to 20 hours after acute SSA and acute CSA, rats 
were killed by decapitation (Figure 1). Chronic CSA rats had one 
cocaine session daily 5 d/wk. Chronic CSA rats were maintained 
a minimum 2 weeks on a FR1 schedule and then changed to 
a FR2 and FR3 schedule (2 and 3 lever presses/cocaine deliv-
ery) and finally to FR5 on which they were maintained for 3 to 
5 weeks before killing (Figure 1; supplementary Figure 1). Total 
length of CSA varied from 6 to 12 weeks (7.8 ± 1.7 weeks, equiva-
lent to 30 to 60 self-administration sessions) depending on rat 
performance and time required by experimenters to process 
brain slices. We previously described that cocaine administered 
at 0.5 mg/kg/injection, 2 h/d at 5 d/wk for a minimum of 6 weeks 
permitted to select rats with a high and stable CSA (Hoffmann 
et  al., 2012). These settings permitted us to obtain “high-
responding rats,” which are likely to reﬂect the main character-
istics of cocaine addiction (Deroche-Gamonet et al., 2004). These 
rats self-administered cocaine on a FR1 schedule from the first 
CSA sessions (Figure  1A; supplementary Figure  1). Rats main-
tained for the study had an average of 24 ± 0.5 lever presses per 
session (FR1-FR5) in contrast to an average lever pressing rate 
of 11.6 ± 1.3 in low-responding rats (supplementary Figure  1B). 
Thirty-one percent of the studied rats did not meet the set cri-
teria within the first 7 days of the study and were consequently 
Figure 1. Behavioral conditioning. Rats who successfully acquired sucrose self-administration (sucrose) underwent surgery (S) where an i.v. catheter was implanted. 
After recovery, sucrose was substituted for i.v. saline (SSA) or cocaine self-administration (CSA, 0.5 mg/kg in 0.1 mL) on a fixed ratio (FR) 1 schedule. Rats were intro-
duced into an operant chamber during a single session (acute) or >6 weeks (chronic) to SSA or CSA. At 16 to 20 hours after the last self-administration session, rats were 
killed by decapitation, except cocaine withdrawal rats, which were killed 60 days after last CSA (CSA withdrawal).
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excluded (supplementary Figure 1B, low responders) (Hoffmann 
et al., 2012). A total of 15 chronic CSA rats were used: 10 were 
killed 16 to 20 hours after the last CSA session and 5 were des-
tined for the chronic CSA withdrawal group (Figure 1). The CSA 
withdrawal rats were maintained in their home cage for 60 days 
before euthanasia. Eleven sham rats were handled daily and 
killed pair-wise with the paired CSA rats. Sham rats received the 
same training, surgery, and treatment as rats destined for self-
administration, except that they never self-administered saline 
or cocaine. Naïve rats were not subject to conditioning or sur-
gery before killing. All killings were carried out between 9 and 11 
am under isoﬂurane anesthesia.
Brain Slice Preparation and Incubation for 
Immunoblotting
Brain slice preparation and Western-blot conditions were 
described previously in detail (Moreno et al., 2011; Hoffmann 
et al., 2012). Immunoblotting was carried out using primary 
antibodies against tyrosine hydroxylase (TH, 1:5000, Chemicon 
AB1542), phospho Thr202 and Tyr204 ERK (1:6000, Cell Signaling 
9101), total ERK (1:5000, Cell Signaling 4695), phospho Ser133 CREB 
(1:3500, Millipore 06-519), GAPDH (1:12000, Cell Signaling 2118), 
total CREB (1:750, Cell Signaling 9197), phospho-ERK 1/2 anti-
body (1:2500, Sigma, M8159, Steinheim, Germany), and ERK 1/2 
antibody that recognizes both phosphorylated and nonphospho-
rylated ERK 1/2 (1:40 000, Sigma, M5670). Horseradish peroxidase-
coupled secondary antibodies used were goat anti-rabbit (1:1000, 
Cell Signaling 7074) and donkey anti-sheep (1:3000, Chemicon 
AP147P). Some ERK1/2 and phosphorylated ERK1/2 blots were 
visualized by the addition of a mixture of IRDye 800 (anti-mouse) 
antibody (1:10 000, Sigma) and IRDye 680 (anti-rabbit) antibody 
(1:10 000, Sigma). After correction for loading variability, Western-
blot results were normalized to controls and expressed as means 
± SEM. Each rat gave rise to various brain slices that were incu-
bated under control and treated conditions generally in duplicate 
or triplicate. The ventro-dorsal, anterior-posterior localization of 
each incubated slice was noted, and treatments were distributed 
throughout the different regions, thus masking any possible 
regional differences in ligand-induced signaling transduction. 
The number of replicates, n, refers to individual slice incubations 
from individual rats. Data was analyzed by ANOVA. 95% CI was 
used to determine statistical significance.
Electrophysiological Recordings
The protocol used was adapted from (Escobar et al., 2011; Marta 
González-Sepúlvedaa, 2013). In brief, brains from naïve rats (5-9 
weeks of age) or rats previously used in behavioral experiments 
(30-32 weeks of age) were extracted and submerged into ice-
cold Krebs buffer containing 124 mM NaCl, 3.5 mM KCl, 25 mM 
NaHCO3, 1.25 mM NaH2PO4, 1 mM CaCl2, 2 mM MgSO4, 10 mM glu-
cose, and 10 mM HEPES (pH 7.4) and cut into sagittal slices (350 
μm). Recordings were done at 30°C to 32°C in Krebs buffer con-
taining 2 mM CaCl2. Field potentials were evoked every 20 sec-
onds in the striatum by stimuli intensity ranging from 100 to 800 
μA for a duration of 80 to 800 microseconds. Hippocampal field 
potentials were evoked every 15 seconds by stimuli intensity 
ranging from 50 to 250 µA for a duration of 50 to 250 microsec-
onds. Field potentials were recorded by a patch-clamp ampli-
fier (Axopatch 200 B, Axon Instruments) and data collected by 
Win LTP (Dr. W. Anderson, University of Bristol, UK). Experiments 
were systematically terminated by applying kynurenic acid (4 
mM). Field potential amplitudes were normalized to baseline 
and expressed as percentage of variation. Each data point is the 
mean of 6 consecutive field potentials for striatum and 8 for hip-
pocampus. Data represent means ± SEM.
Drugs
(RS)-3,5-Dihydroxyphenylglycine (DHPG), 2-methyl-6-
(phenylethynyl)pyridine hydrochloride (MPEP), kynurenic acid, 
7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl 
ester, (S)-(+)-alpha-Amino-4-carboxy-2-methylbenzeneacetic 
acid, 2,3-dihydro-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, 
1,4-Diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene 
(U0126), and kynurenic acid were obtained from Tocris or Ascent. 
All dilutions were done in Krebs buffer. Antagonists were applied 
10 minutes prior to agonists. For immunoblot analysis, U0126 
was added 20 minutes prior to DHPG. Stock solution of U0126 
was prepared in DMSO. Cocaine hydrochloride was obtained 
from the Ministerio de Sanidad y Consumo, Spain, and dissolved 
in physiological saline and sterile filtered for i.v. administration.
Results
Metabotropic GluR1/5 Promote ERK1/2 
Phosphorylation in Ex Vivo Striatal Slices
To determine how mGluR1/5 coupling to ERK1/2 was affected over 
time during CSA (Figure 1), we first validated our experimental 
set-up. To establish the time frame and concentration of ligand, 
we applied the selective mGluR1/5 agonist DHPG (10 and 100 μM) to 
striatal slices from naïve rats. We found that DHPG 10 μM increased 
ERK1/2 phosphorylation to a greater degree than DHPG 100 μM at 
the studied time points, reaching maximal levels after 5 to 10 min-
utes of incubation (Figure 2A-B). Based on this, we used 10 μM for 
the remaining studies. The striatum is enriched with dopamin-
ergic terminals containing the dopamine-synthesizing enzyme 
TH. To control for correct tissue dissection, we systematically veri-
fied the slices were enriched with TH. Approximately 2% of slices 
were discarded due to low or absent TH. To establish whether 
DHPG-associated responses in striatal slices were dependent on 
both mGluR1 and mGluR5, we applied either receptor antagonists 
prior to DHPG and evaluated ERK1/2 activation. In the presence of 
the selective mGluR1 antagonist, 7-(Hydroxyimino)cyclopropa[b]
chromen-1a-carboxylate ethyl ester, CPCCOEt (100 μM, 20 min-
utes) or the mGluR5 antagonist, MPEP (20 μM, 20 minutes), DHPG-
induced ERK1/2 phosphorylation was abolished (Figure 2C).
Chronic CSA and Prolonged CSA Withdrawal 
Disrupts mGluR1/5 Coupling to ERK1/2 in the Dorsal 
Striatum
In agreement with others (Lenoir et  al., 2007; Schmidt et  al., 
2015), we found sucrose self-administration to be highly reward-
ing in rats, as evidenced by the high number of lever presses on 
the active lever (+) during the first session of self-administration 
after substituting sucrose by saline (Figures 1 and 3A, saline). 
The high responding on the active lever (+) in the acute SSA 
group likely reﬂects a dissatisfying search for sucrose. In line 
with this, the subjective effects of cocaine were revealed by the 
lower number of active lever (+) presses in the acute CSA group 
compared with the acute SSA (Figure  3A). The acute CSA ani-
mals did show preference for the active lever (+), although the 
total number of lever presses was significantly lower than in the 
acute SSA group (Figure 3A, cocaine). To establish how different 
stages of CSA affected mGluR1/5 coupling to ERK1/2, we evaluated 
 by guest on O
ctober 25, 2016
http://ijnp.oxfordjournals.org/
D
ow
nloaded from
 
 Hoffmann et al. | 5
DHPG-mediated ERK1/2 activation in striatal slices from acute 
CSA, chronic CSA, and cocaine withdrawal rats. Interestingly, 
there was a time-dependent effect on the capacity for DHPG to 
induce ERK1/2 phosphorylation, where acute CSA had no effect 
(Figure 3B-C), chronic CSA decreased or abolished (Figure 3D-E) 
and a 60-day withdrawal from chronic CSA abolished DHPG-
ERK1/2 activation (Figure 3F-G). It has been reported that mGluR5 
can acquire constitutive activity (Ango et al., 2001; Muhlemann 
et  al., 2005). To explore this possibility, we used the mGluR5 
antagonist/inverse agonist MPEP. Application of MPEP (10 µM, 10 
minutes) did not elicit any changes of basal phosphorylation of 
ERK1/2 in any of the studied conditions (Figure 3C, E, G, MPEP).
CSA Abolishes DHPG-LTD and DHPG-Induced CREB 
Phosphorylation in the Dorsal Striatum
Cocaine addiction induces long-lasting effects on cellular func-
tion, synaptic plasticity, and memory formation (Huang et al., 
2011). These effects are in part mediated by glutamate and 
induction of transcription factors, such as CREB. We therefore 
asked if the loss of DHPG-induced ERK1/2 phosphorylation 
following CSA would lead to long-lasting changes of syn-
aptic plasticity. Due to the technical difficulty to distinguish 
between dopamine D1 and D2 receptor-expressing medium 
spiny neurons of the rat striatum, we decided to evoke field 
potentials at cortico-striatal afferents in the dorsal stria-
tum to obtain a general image of mGluR1/5-mediated synaptic 
plasticity. The stimulation of cortico-striatal afferents evoked 
both positive and negative going extracellular field potentials 
in the striatum of naive rats, which were sensitive to AMPA/
kainate receptor blockade with the selective antagonist, 
2,3-dihydro-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (10  μM, 
10 minutes) (supplementary Figure 2A) and with the nonselec-
tive glutamate ionotropic receptor antagonist, kynurenic acid 
(Figure  4F). This confirmed the requirement of the synaptic 
release of glutamate for their occurrence. The application of 
DHPG (10 µM, 10 minutes) resulted in a long-lasting reduction 
of field potentials (supplementary Figure 2B; Fig. 4A, DHPG). On 
average field potential amplitude decreased to 69 ± 7% (n = 9) 
of baseline (102 ± 2%) during perfusion of DHPG and remained 
reduced for >40 minutes after DHPG washout (47 ± 2% of base-
line, n = 9). DHPG-LTD was observed on both negative and posi-
tive going field potentials (supplementary Figure  2B-C). The 
analysis of the paired-pulse ratios revealed an increased ratio 
after DHPG application (supplementary Figure 2D), indicating a 
presynaptic expression of DHPG-LTD. DHPG-LTD in other brain 
regions depends on ERK1/2 phosphorylation (Gallagher et al., 
2004; Grueter et al., 2006). Thus, we next evaluated the role of 
ERK1/2 in the induction of DHPG-LTD in the dorsal striatum. 
Application of the specific mitogen-activated protein kinase 
kinase inhibitor U0126 prior to DHPG prevented DHPG-LTD 
expression (Figure 4A) and abolished ERK1/2 and CREB phos-
phorylation (Figure 4B-C, nuclear localization of CREB was con-
firmed; supplementary Figure 3). DHPG-LTD required activation 
of both mGluR1 and mGluR5 (Figure 4D-E) as evidenced by the 
capacity of the mGluR1 antagonist, (S)-(+)-alpha-Amino-4-
carboxy-2-methylbenzeneacetic acid (50 μM), and the mGluR5 
antagonist, MPEP (10  μM), to inhibit DHPG-LTD (LY367386: 
98 ± 5%, n = 6; MPEP: 98 ± 4%, n = 7 compared with baseline). The 
requirement of ERK1/2 activation for DHPG-LTD and the lack of 
DHPG-induced ERK1/2 phosphorylation after CSA withdrawal 
led us to hypothesize that DHPG-LTD would be abolished after 
CSA withdrawal. Indeed, 60 days after CSA withdrawal, DHPG 
was unable to induce a cortico-striatal LTD (Figure 4F). In con-
trast, DHPG-induced LTD in the hippocampal CA1 area was 
normal in slices from the same group of animals (supplemen-
tary Figure 4). The loss of both DHPG-induced ERK1/2 phospho-
rylation and LTD in the striatum after chronic CSA withdrawal 
suggest that CREB, a downstream target of ERK1/2, could be 
involved in the maintained effects of CSA on synaptic plastic-
ity. Surprisingly, both acute and chronic CSA had a blunting 
effect on the capacity of DHPG to induce CREB phosphoryla-
tion in the dorsal striatum (Figure  5A-D), whereas MPEP had 
no effect in any of the studied groups (Figure 5B, D, MPEP). In 
contrast to DHPG-induced ERK1/2 phosphorylation (Figure 2C), 
DHPG-induced CREB phosphorylation relied principally on 
mGluR5 (Figure 5E).
Figure 2. (RS)-3,5-Dihydroxyphenylglycine (DHPG)-induces extracellular signal-
regulated protein kinases 1/2 (ERK1/2) phosphorylation in ex vivo striatal slices 
of naive rats. DHPG-mediated ERK1/2 (A-B) phosphorylation in the presence or 
absence (C) of group I metabotropic glutamate receptors (mGluR1) antagonist 
7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) 
(100 μM) or mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine hydrochloride 
(MPEP) (20 μM). The analysis of ERK1/2 phosphorylation was performed on 9 to 30 
slices from 5 to 6 animals. Statistical analysis was done by 1-way or 2-way ANOVA, 
*P < .05; **P < .01 compared with control or as indicated by bar.
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Signaling Shift of mGluR1/5 in the Nucleus 
Accumbens by Chronic CSA
Numerous studies have shown evidence of alterations of synap-
tic transmission in the nucleus accumbens after cocaine admin-
istration (Backstrom and Hyytia, 2007; Moussawi et al., 2009). We 
therefore decided to examine whether mGluR1/5 signaling was 
also affected in our conditions. Due to the size of the accum-
bens, we did not separate the core and shell regions for the bio-
chemical analysis. The data obtained thus reﬂects the overall 
effect of treatment of both accumbal subregions. In the accum-
bens, chronic CSA strongly decreased DHPG-induced signaling 
to ERK1/2 and CREB (Figure 6A-D). To assess a possible constitu-
tive activity of mGluR5 after chronic CSA, we applied MPEP to 
the slices. MPEP (10 µM, 10 minutes) did not alter basal phospho-
rylation of ERK1/2 or CREB in sham rats (Figure 6B, D, white col-
umns). Surprisingly, chronic CSA led to a strong enhancement 
of CREB phosphorylation induced by MPEP (10 µM, 10 minutes) 
(Figure 6D).
Discussion
We provide evidence here that depending on the CSA stage 
(acute, chronic, withdrawal), the capacity of mGluR1/5 to stimulate 
specific downstream signaling cascades is altered. Interestingly, 
specifically in the nucleus accumbens, chronic CSA also leads 
to a gain of mGluR5 function that could be interpreted as an 
increase in its constitutive activity.
Limitations of Rodent CSA Paradigms and Their 
Validity as Study Models for Human Addiction
Repeated CSA is a complex behavior, where the rewarding 
effects of this drug change with its concentration as well as 
mode and speed of administration. Depending on the specific 
rodent drug self-administration paradigm used, specific fea-
tures of human drug abuse can be evaluated (Panlilio et al., 
2005; Sughondhabirom et al., 2005; Panlilio and Goldberg, 2007). 
Although it has been established that repeated cocaine con-
sumption triggers long-lasting changes in brain plasticity, which 
contribute to drug craving during abstinence and might induce 
relapse into cocaine-seeking behavior, we still have a very lim-
ited understanding of the exact molecular changes in the brain, 
which is reﬂected by the poor success in developing efficient 
drugs for cocaine addiction (Shorter et al., 2015; Wolf, 2016). To 
increase our understanding of the changes taking place in the 
striatum from the first CSA to chronic CSA through CSA with-
drawal, we studied the progression of mGluR1/5 responses in stri-
atal slices. Although the validity of the chronic CSA model has 
proven to reﬂect numerous aspects of human cocaine addiction 
Figure 3. Chronic cocaine self-administration (CSA) specifically abolished (RS)-3,5-Dihydroxyphenylglycine (DHPG)-induced ERK1/2 phosphorylation in the striatum. 
(A) Cumulated number of lever presses during the initial session of 2 hours of saline (SSA) or cocaine (CSA) at fixed ratio 1 (FR1) after replacing sucrose with cocaine. 
Representative immunoblots (B, D, F) and histograms (C, E, G) of DHPG and 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP)-mediated ERK1/2 phosphoryla-
tion in striatal slices from acute (B-C), chronic (D-E), and cocaine withdrawn (F-G) rats. +, active lever; -, inactive lever; s, sham; c, cocaine. n = 6 to 10 rats. Two-way 
ANOVA, *P < .05; **P < .01; ***P < .001 compared with control or as indicated by bar.
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(Deroche-Gamonet et al., 2004; Grueter et al., 2006; Kasanetz 
et al., 2010; Mihov and Hasler, 2016; Perry et al., 2016), it is still 
unclear whether a forced i.p. cocaine administration or a single 
CSA session best reﬂects the acute effects of cocaine. We believe 
CSA best reﬂects the motivation to administer drugs, as seen in 
humans, and the final dose self-administered is chosen by the 
animal and thus it would hardly be aversive. We therefore chose 
a single CSA session over forced i.p. delivery. There are, however, 
important limitations using this model that need to be taken 
into account. While rats in our study were allowed control of the 
cocaine dose received during the first session they expected to 
receive sucrose, not cocaine. To discriminate cocaine effects from 
sucrose expectation, we compared self-administration behavior 
in acute SSA and acute CSA rats. The high number of active lever 
presses in the SSA group indicates that rats undergo sucrose 
extinction (Knackstedt et al., 2010). However, acute SSA (or a 
sucrose extinction session) did not alter the capacity of mGluR1/5 
to elicit ERK1/2 or CREB phosphorylation. This indicates that 
mGluR1/5 coupling to these 2 proteins is intact after an acute SSA.
Progressive Loss of mGluR1/5 Function in the Dorsal 
Striatum during CSA and CSA Withdrawal
Cocaine administration is accompanied by a decreased expres-
sion of mGluR5 in the striatum of rodents (Ghasemzadeh et al., 
2009; Knackstedt et  al., 2010; Pomierny-Chamiolo et  al., 2015) 
and humans (Martinez et al., 2014; Milella et al., 2014) and has 
been shown to reduce mGluR5 responses (Swanson et al., 2001; 
McCutcheon et al., 2011). Although repeated cocaine administra-
tion decreases dopamine D2 receptor expression in the ventral 
striatum, paradoxically they couple more efficiently to down-
stream cascades, leading to increased signal-transduction (Bailey 
et al., 2008; Hoffmann et al., 2012). Thus, to increase our under-
standing of how mGluR1/5 functions in states of disease, such 
as cocaine addiction, it is important to address both receptor 
expression and isoforms as well as their capacity to signal and 
modulate synaptic plasticity. It has previously been shown that 
mGluR1/5 promote ERK1/2 and CREB phosphorylation (Mao et al., 
2008), 2 kinases associated with both acute and prolonged effects 
of cocaine. CREB activity affects learning and memory processes 
by regulating experience-based gene transcription amending to 
long-lasting neuro-adaptations (McClung and Nestler, 2008). In 
addition, it is believed that CREB activation in the dorsal striatum 
controls drug-associated memory (Fasano et al., 2009) as well as 
cocaine reinforcement (Hollander et al., 2010). The important role 
of the glutamatergic system in the progression to addiction-like 
behavior is supported by our data showing a lessened function 
of mGluR1/5 signaling to ERK1/2 and CREB in the dorsal striatum 
after CSA. Interestingly, DHPG-induced CREB activation was 
more sensitive to CSA than ERK1/2 activation. Only chronic CSA, 
and its withdrawal, was able to abolish ERK1/2 phosphorylation, 
whereas a blunting of DHPG-induced CREB phosphorylation was 
seen as early as the first CSA, an effect that appeared more pro-
nounced after chronic CSA and withdrawal. Our data suggest 
that acute CSA only affects DHPG-mediated CREB phosphoryla-
tion due to the ability of both mGluR1 and mGluR5 to regulate 
Figure 4. Cocaine withdrawal leads to loss of group I metabotropic glutamate receptors (mGluR1/5)-mediated long-term depression (LTD). The MEK inhibitor U0126 
abolished (RS)-3,5-Dihydroxyphenylglycine (DHPG)-induced LTD (A), CREB phosphorylation (pCREB) (B-C), and ERK1/2 phosphorylation (pERK) (C) in striatal slices of 
naive rats. LTD was blocked with the metabotropic glutamate 5 receptor (mGluR5) antagonist 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP) (D) as well 
as with the mGluR1 antagonist (S)-(+)-alpha-Amino-4-carboxy-2-methylbenzeneacetic acid (LY367385) (E) in naive rats. (B) The analysis of pCREB was normalized to 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and is representative of 8 to 12 slices from 4 to 6 animals. Statistical analysis by 1-way ANOVA, **P < .01 compared 
with control or as indicated by bar. (A,D-F) Data are expressed as normalized field potential amplitude to baseline and expressed as percentages. They are means ± SEM. 
Inset, representative field potential traces during baseline recording and 40 minutes after wash-out, horizontal bar indicates 5 milliseconds, vertical bar 50 μV. (F) Sixty-
day withdrawal from chronic cocaine self-administration (CSA) abolished DHPG-LTD in the striatum.
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ERK1/2 phosphorylation, whereas CREB phosphorylation solely 
relies on mGluR5. The mechanisms of the blunted induction 
of ERK1/2 and CREB phosphorylation agree with the decrease 
of mGluR5 observed by others in this structure (Ghasemzadeh 
et  al., 2009; Knackstedt et  al., 2010; Pomierny-Chamiolo et  al., 
2015). Taken together, this progressive loss of signaling through 
the mGluR5 pathway after prolonged CSA and withdrawal sug-
gest a critical role of mGluR5 in cocaine addiction. As negative 
allosteric modulators are promising drugs for the treatment of 
cocaine addiction (Panlilio et al., 2005; Mihov and Hasler, 2016), it 
will be interesting to further the current study and determine on 
a molecular level how these drugs function in the addicted brain.
Prolonged Cocaine Withdrawal Abolishes DHPG-
Mediated LTD and ERK1/2 Phosphorylation in the 
Dorsal Striatum
The expression of striatal LTD shapes goal-directed learning, and 
its loss correlates with the progression to addiction-like behavior 
(Moussawi et al., 2009; Kasanetz et al., 2010; Huang et al., 2011). 
Metabotropic GluR1/5 are central in the modulation of striatal 
plasticity, which involves both these receptor subtypes, mutually 
with dopamine and endocannabinoid CB1 receptors (Sung et al., 
2001; Mao et al., 2005; Chepkova et al., 2009). Repeated involun-
tary administration of cocaine leads to a progressive inhibition of 
DHPG-induced mGluR1/5 activation and LTD in the core nucleus 
accumbens, lasting up to 28 days after cocaine administration 
(Huang et al., 2011), whereas 3 weeks of cocaine abstinence after 
short-term self-administration abolishes striatal LTD expression 
(Knackstedt et al., 2014). Both the loss of DHPG-LTD and a reduc-
tion of CREB activation could be permissive to cocaine addiction-
like behavior (Martin et al., 2006; Fasano et al., 2009; Hollander 
et al., 2010; Kasanetz et al., 2010; Milella et al., 2014). Consistent 
with this, we found that the induction of DHPG-LTD in striatal 
slices was abolished after a 60-day CSA withdrawal. Repeated 
administration of cocaine has previously been associated with 
loss of LTD in various brain structures (Grueter et  al., 2006; 
Backstrom and Hyytia, 2007; Moussawi et  al., 2009; Kasanetz 
et al., 2010). Our study expands these findings by showing that in 
the striatum, both mGluR1/5-LTD and mGluR1/5-ERK1/2 phospho-
rylation were lost after chronic CSA withdrawal.
The blunting of DHPG-induced ERK1/2 phosphorylation 
most likely contributes to the loss of DHPG-LTD, given ERK1/2 
is necessary for DHPG-LTD in the striatum. This finding is in 
agreement with the disappearance of DHPG-LTD in other brain 
regions after prolonged withdrawal from forced cocaine injec-
tions (Grueter et al., 2006; Huang et al., 2011). Interestingly, we 
found that prolonged withdrawal from chronic CSA specifically 
abolished DHPG-LTD in the striatum without affecting it in the 
CA1 region of the hippocampus in these same animals. We pro-
pose that the long-term loss of striatal DHPG-LTD is related to 
the long-term effects of cocaine addiction in the brain, which 
contributes to the formation of habits established during vol-
untary drug use. Remarkably, the loss of LTD after prolonged 
withdrawal of cocaine administration appears unrelated to the 
way of administration as the loss of DHPG-LTD occurred both 
after voluntary (current study) as well as involuntary (Huang 
et al., 2011) cocaine administration. We believe the loss of stri-
atal DHPG-LTD to be responsible for facilitating the enduring 
memory of cocaine exposure for up to 60 days after the last CSA.
Possible Gain of Constitutive Activity of mGluR5 
Specifically in the Accumbens after Chronic CSA
The nucleus accumbens is required for both natural and drug-
induced reward (Carlezon et  al., 1998; Kalivas et  al., 2005; 
Kalivas and Volkow, 2005). Phosphorylation of accumbal ERK1/2 
and CREB participates in cocaine sensitization and reward and 
Figure 5. Loss of (RS)-3,5-Dihydroxyphenylglycine (DHPG)-mediated CREB phos-
phorylation (pCREB) with cocaine self-administration (CSA). Illustrative immu-
noblots (A,C) and histograms (B-E) of DHPG-induced pCREB in striatal slices 
from acute (A-B), chronic CSA (C-D), and naïve (E) rats. (E) Striatal metabotropic 
glutamate 5 receptor (mGluR5)-induced pCREB was blocked with the mGluR5 
antagonist 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP), but not 
the mGluR1 antagonist 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate 
ethyl ester (CPCCOEt). Two-way ANOVA,*P < .05; *** P < .001 compared with control 
or as indicated by horizontal bar; n.s., nonsignificant (P > .05). n = 5 to 7.
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contributes to motivation for cocaine (Carlezon et  al., 1998; 
Valjent et al., 2000; Valjent et al., 2006; Kong et al., 2011; Larson 
et al., 2011). Interestingly, we found that CSA reduced agonist-
induced mGluR5 responses in the nucleus accumbens and 
that the mGluR5 antagonist/inverse agonist MPEP specifically 
increased CREB and not ERK1/2 phosphorylation after CSA. 
MPEP has previously proven capable of revealing mGluR5 con-
stitutive activity (Ango et al., 2000; Muhlemann et al., 2005). It 
is thus possible the MPEP mediated increase in CREB phospho-
rylation in the nucleus accumbens might reﬂect a gain of con-
stitutive activity of the mGluR5 or increased glutamate levels 
in these slices after chronic CSA and thus represents a means 
for cocaine to facilitate cocaine-induced behavior and memory. 
We did not observe any changes in basal phosphorylation or 
a proper effect of MPEP in the striatum in any of our experi-
mental groups, supporting the idea that mGluR5 developed a 
constitutive activity after prolonged CSA. More research is war-
ranted to understand how the switch from an agonist-activated 
receptor to a constitutive active receptor occurs and what the 
role is. In addition, alternative recruitment of signaling path-
ways linked to mGluR5 function must be considered. Both the 
loss of LTD and the reduction of CREB activation are permis-
sive to cocaine addiction-like behavior (Self et al., 1998; Martin 
et al., 2006; Fasano et al., 2009; Kasanetz et al., 2010); thus the 
increased inhibition of CREB through accumbal mGluR5 would 
favor cocaine addiction behavior. One possibility is a change in 
the recruitment of scaffolding proteins associated with mGluR5 
such as Homer, Shank, and postsynaptic density protein-95, cer-
tain of which have been shown to be involved in cocaine-medi-
ated behavior (Swanson et al., 2001; Wang et al., 2013; Bakshi 
et al., 2014; Martinez et al., 2014). The complexity of cocaine-
induced changes to signaling transduction pathways and the 
validity of rodent models to develop new treatment strategies 
has recently been reviewed and highlights the importance of 
continuing our efforts in elucidating the molecular changes in 
signaling transduction in order to develop better drug targets 
for the treatment of cocaine addiction (Terbeck et  al., 2015; 
Garcia-Pardo et al., 2016; Mihov and Hasler, 2016).
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